Device Trial Radar · NCT02353533
Endoscopic Full-thickness REsection of Residual Colorectal Lesions - The FiRE Study
Last checked: Nov 19, 2026Latest source record: Nov 21, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
40
Planned (sponsor's estimate)
Start
Jan 2015
Primary completion
Oct 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- Technical University of MunichAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 2, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Adenomatous lesions of the colon are premalignant lesions which have the potential to develop cancer. Therefore adenomas should be resected endoscopically (endo- mucosa resection, EMR). EMR is conducted after submucosal injection of saline which allows to lift the desired lesion prior to resection. In some cases EMR is complicated due to incomplete or failed lifting after the injection of saline. This so- called "non- lifting" sign is a predictor for malignancy of the lesion. Difficult- to- lift polyps are also difficult- to- resect. A higher proportion of these lesions fail to be resected completely using the EMR technique. Alternatively, an over- the- scope full- thickness resection device (FTRD) can be used in order to resect colonic lesions. The FTRD technique has been described elsewhere (Schmidt et al. Gastroenterology 2014; 147: 740-742.e2). No comparative data exists until now on the performance of FTRD resection compared to standard EMR resection of difficult- to- resect colon adenomas. In this study the investigators aim to compare the success of FTRD versus EMR of difficult- to- resect adenomatous lesions (≤ 20 mm).
Conditions
- Adenoma
Interventions
over- the- scope full- thickness resection device (FTRD)Device
Endoscopic resection of adenomatous lesions of the colon using the over- the- scope full- thickness resection device
EMRDevice
Standard endoscopic mucosal resection using a resection snare
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success of resectionTime frame: 3 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München
Munich, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.